NorthWest Biotherapeutics Inc (NWBO)

[TZOR]

I honestly think you are confusing two arguments. 1. Who owns the proerty? 2, Who will manufacture the product?

Answer to #1, NWBO owns the property in the UK.

Your original post references the purchase or sale of property, not a manufacturing agreement.

Answer to #1, NWBO will manufacture the product moving forward in the UK/Europe

NWBO has been using the Cognate facilities to complete their work because they do not have the infrastructure in place to do it themselves. As you can see they are planning to do it themselves in the UK and Europe. The next question is what will happen in the US? They may continue to use Cognate, they may branch out on their own. I don't think NWBO is going to branch out on their own for manufacturing in the US.

Just read your link, Acaris is a subsidiary of NWBO and owned by NWBO. Cognate is listed as Guarantor, that means they will guarantee the the contract in the event that Acaris defaults. You ask Why, then you inject opinion. There is nothing in the link provided that states Cognate will occupy the building, period. That is not the sole reason why 3rd parties act as guarantors in corporate real estate investments.

You have not proven your point.

I have proven that NWBO owns the property (as listed on the financial statements listed with SEC), which initially was your argument before your confused and combined two arguments into one.

Please note your original comment

10.1 Contract for the Sale and Purchase of Land and Buildings at Sawston, England, dated July 3, 2014, by and among Spicers Limited, Aracaris Capital Limited and Cognate Bioservices, Inc.

Your post does not argue for manufacturing, it is an argument of ownership. I just proved that NWBO owns the property.